Detalhe da pesquisa
1.
Impact of 10-Valent Pneumococcal Conjugate Vaccine Introduction on Pneumococcal Carriage and Antibiotic Susceptibility Patterns Among Children Aged <5 Years and Adults With Human Immunodeficiency Virus Infection: Kenya, 2009-2013.
Clin Infect Dis
; 70(5): 814-826, 2020 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30959526
2.
Patient and provider perspectives on how trust influences maternal vaccine acceptance among pregnant women in Kenya.
BMC Health Serv Res
; 19(1): 747, 2019 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31651307
3.
Decision-making process for introduction of maternal vaccines in Kenya, 2017-2018.
Implement Sci
; 16(1): 39, 2021 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33845842
4.
Drivers and barriers of vaccine acceptance among pregnant women in Kenya.
Hum Vaccin Immunother
; 16(10): 2429-2437, 2020 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32208952
5.
Improving Capture of Vaccine History: Case Study from an Evaluation of 10-Valent Pneumococcal Conjugate Vaccine Introduction in Kenya.
Am J Trop Med Hyg
; 94(6): 1400-2, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27139446
6.
Risk of Injection-Site Abscess among Infants Receiving a Preservative-Free, Two-Dose Vial Formulation of Pneumococcal Conjugate Vaccine in Kenya.
PLoS One
; 10(10): e0141896, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26509274